Heracleifolinosides A–F, New Triterpene Glycosides from Cimicifuga heracleifolia, and Their Inhibitory Activities against Hypoxia and Reoxygenation

Abstract

Six new 9,19-cycloartane triterpene glycosides, heracleifolinosides A–F (1–6), and one new chromone, norkhelloside (7), were isolated from the rhizome of Cimicifuga heracleifolia, together with 15 known compounds (8–22). The structures of the new compounds were elucidated by means of spectroscopic methods including 2D NMR and mass spectrometry. The extracts of C. heracleifolia and all the isolated compounds were tested for activities against hypoxia and reoxygenation injury in human umbilical vein endothelial cells. Heracleifolinoside B (2) is effectively resistant to hypoxia and reoxygenation-induced human umbilical vein endothelial cell injury, with cell viabilities of 61.95 ± 2.04 %, 77.04 ± 4.44 %, and 83.65 ± 3.29 % at concentrations of 1, 10, and 100 µM, respectively.

Key words

Cimicifuga heracleifolia - Ranunculaceae - 9,19-cycloartane triterpene bisglycosides - hypoxia - reoxygenation

^* These two authors contributed equally to the work reported in this article.

• References

• 1 China Pharmacopoeia Committee. Pharmacopoeia of the P.R.C., The first division of 2005 edition. Beijing: Chemical and Technologic Press; 2005: 50-51
• 2 New Medical College of Jiangsu. Dictionary of Chinese Materia Medica, Vol. 1. Shanghai: Shanghai Scientific and Technological Press; 1977: 451-454
• 3 Sun LR, Qing C, Zhang YL, Jia SY, Li ZR, Pei SJ, Qiu MH, Gross ML, Qiu SX. Cimicifoetisides A and B, two cytotoxic cycloartane triterpenoid glycosides from the rhizomes of Cimicifuga foetida, inhibit proliferation of cancer cells. Beilstein J Org Chem 2007; 3: 3-8
• 4 Liu Y, Chen DH, Si JY, Tu GZ, An DG. Two new cyclolanostanol xylosides from the aerial parts of Cimicifuga dahurica . J Nat Prod 2002; 65: 1486-1488
• 5 Takahira M, Kusano A, Shibano M, Kusano G, Sakurai N, Nagai M, Miyase T. Three new fukiic acid esters, cimicifugic acids A, B and C, from Cimicifuga simplex Wormsk. Chem Pharm Bull 1998; 46: 362-365
• 6 Atsufumi I, Genjiro K, Tsutomu W, Toshio MH. Hyaluronidase inhibitors from “Cimicifugae Rhizoma” (a mixture of the rhizomes of Cimicifuga dahurica and C. heracleifolia). J Nat Prod 2010; 73: 573-578
• 7 Chen SN, Li WK, Fabricant DS, Santarsiero BD, Mesecar A, Fitzloff JF, Fong HH, Farnsworth NR. Isolation, structure elucidation, and absolute configuration of 26-deoxyactein from Cimicifuga racemosa and clarification of nomenclature associated with 27-deoxyactein. J Nat Prod 2002; 65: 601-605
• 8 Ito M, Kondo Y, Takemoto T. Spasmolytic substances from Cimicifuga dahurica Maxim. Chem Pharm Bull 1976; 24: 580-583
• 9 Compton JA, Culham A, Jury SL. Reclassification of Actaea to include Cimicifuga and Souliea (Ranunculaceae): phylogeny inferred from morphology, nrDNA ITS, and cpDNA trnL-F sequence variation. Taxon 1998; 47: 593-634
• 10 Compton JA, Culham AJ, Gibbings G, Jury SL. Phylogeny of Actaea including Cimicifuga (Ranunculaceae) inferred from nrDNA ITS sequence variation. Biochem Syst Ecol 1998; 26: 185-197
• 11 Shao Y, Amanda H, Wang MF, Zhang HJ, Geoffrey C, Mika B, Lemmo E. Triterpene glycosides from Cimicifuga racemosa . J Nat Prod 2000; 63: 905-910
• 12 Lin YP, Qiu MH, Li ZR. Studies on the chemical constituents and biologic activities of Cimicifuga . Nat Prod Res Dev 2002; 14: 58-76
• 13 Li JX, Yu ZY. Cimicifugae Rhizoma: from origins, bioactive constituents to clinical outcomes. Curr Med Chem 2006; 13: 2927-2951
• 14 Li JX, Kadota S, Hattori M, Yoshimachi S, Shiro M, Oogami N, Mizuno H. Constituents of Cimicifugae Rhizoma. I. Isolation and characterization of ten new cycloartenol triterpenes from Cimicifuga heracleifolia Komarov. Chem Pharm Bull 1993; 41: 832-841
• 15 Kusano G, Uchida H, Murakami Y, Sakurai N, Takemoto T. Studies on the constituents of Cimicifuga spp. XII. A revised structure of acerinol and the structures of the related compounds. Yakugaku Zasshi 1976; 96: 321-323
• 16 Kusano G, Hojo S, Kondo Y, Takemoto T. Studies on the constituents of Cimicifuga spp. XIII. Structure of cimicifugoside. Chem Pharm Bull 1977; 25: 3182-3184
• 17 Zhang QW, Ye WC, Hao WL, Zhao SX, Che ZT. Cycloartane glycosides from Cimicifuga dahurica . Chem Pharm Bull 2001; 49: 1468-1470
• 18 Akiko K, Masayuki T, Makio S, Yasuko I, Toshimasa I, Toshio M, Genjiro K. Studies on the constituents of Cimicifuga species. XX. Absolute stereostructures of cimicifugoside and actein from Cimicifuga simplex Wormsk. Chem Pharm Bull 1998; 46: 467-472
• 19 Li CJ, Chen DH, Xiao PG. Chemical constituents of traditional Chinese drug “Sheng-ma” (Cimicifuga dahurica). III. Structures of cimicifugamide. Acta Chim Sin 1995; 52: 296
• 20 Ding PY, Zhu XX, Cai MS, Yu DQ. Studies on synthesis and pharmacological activities of cimicifugamide from Cimicifuga dahurica, and its analogues. Acta Pharm Sin 1997; 32: 755-760
• 21 Song ZH, Wang BD, Ba H, Tong XT, Zhu DY, Jiang FX. Studies on chemical constituents in roots of Paeonia sinjiangensis . China J Chin Mater Med 2004; 29: 748-751
• 22 Klaus PL, Maki K, Andreas S, Herbert K. An ellagitannin, n-butyl gallate, two aryltetralin lignans, and an unprecedented diterpene ester from Pelargonium reniforme . Phytochemistry 2008; 69: 820-826
• 23 Li BG, Zhou ZZ. Chemistry of the new drug Di Ao Xin Xue Kang for treating cardiovascular diseases. Chin J New Drugs Clin Rem (in Chinese) 1994; 13: 75-76
• 24 Tsuyoshi I, Hidetsugu T, Masafumi O, Toshihiro N. Pregnane- and furostane-type oligoglycosides from the seeds of Allium tuberosum . Chem Pharm Bull 2004; 52: 142-145
• 25 Hua HM, Li X, Pei YH. The special characterization of Cycloartane triterpenoids. Nat Prod Res Dev 2000; 13: 65-70
• 26 Lu L, Chen JC, Song HJ, Li Y, Nian Y, Qiu MH. Five new triterpene bisglycosides with acyclic side chains from the rhizomes of Cimicifuga foetida L. Chem Pharm Bull 2010; 58: 729-733
• 27 Minpei K, Singo U, Kazuki W, Yoshihiro M. Chromones from the tubers of Eranthis cilicica and their antioxidant activity. Phytochemistry 2009; 70: 288-293